Aminoglycosides and other factors promoting stop codon readthrough in human cells
Authors:
- Céline ChauvinCCCéline Chauvin
- Olivier Jean-JeanOJOlivier Jean-Jean
- 18 October 2006
- journal article
- Published by MathDoc/Centre Mersenne in Comptes Rendus. Biologies
- Vol. 330 (1) , 71-79
Abstract
Enhanced stop codon readthrough is a potential treatment strategy for diseases caused by nonsense mutations. Here, we compare readthrough levels induced by three types of factors: aminoglycoside antibiotics, suppressor tRNAs, and factors decreasing translation termination efficiency. We show that the highest levels of readthrough were obtained by prolonged treatment with aminoglycosides and suppressor tRNAs, whereas prolonged depletion of release factors induced only a moderate increase in readthrough. We discuss the benefits and inconvenients of the three types of factors for their use in the therapy of diseases caused by premature stop codons.Keywords
This publication has 33 references indexed in Scilit:
- Aminoglycoside suppression of nonsense mutations in severe hemophiliaBlood, 2005
- A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapyBrain and Development, 2005
- Involvement of Human Release Factors eRF3a and eRF3b in Translation Termination and Regulation of the Termination Complex FormationMolecular and Cellular Biology, 2005
- Pharmacologic therapy for stop mutations: how much CFTR activity is enough?Current Opinion in Pulmonary Medicine, 2004
- Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivoHuman Molecular Genetics, 2004
- Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatmentGene Therapy, 2004
- Stop codon suppression via inhibition of eRF1 expressionRNA, 2003
- A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factorNature, 1994
- The 3′ Codon Context Effect on UAG Suppressor tRNA is Different in Escherichia coli and Human CellsJournal of Molecular Biology, 1993
- Construction of a functional human suppressor tRNA gene: an approach to gene therapy for β-thalassaemiaNature, 1982